Go to:
Logótipo
Você está em: Start > Publications > View > Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
Publication

Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma

Title
Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
Type
Article in International Scientific Journal
Year
2022-01-25
Authors
Maria J. Ramalho
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Joana A Loureiro
(Author)
FEUP
View Personal Page Send message Search for Participant Publications View Authenticus page Without ORCID
coelho, man
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Maria do Carmo Pereira
(Author)
FEUP
View Personal Page Send message Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: PharmaceuticsImported from Authenticus Search for Journal Publications
ISSN: 1999-4923
Publisher: MDPI
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge
Other information
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

The use of nanomaterials for cancer and neurodegeneration:nanocarriers, biomembranes and immunosensors (2019)
Poster in an International Conference
Maria Ramalho; Joana A Loureiro; Manuel Coelho; Maria do Carmo Pereira
Solid Lipid Nanoparticles forGlioblastoma Multiforme therapy (2018)
Poster in an International Conference
Maria Ramalho; Stephanie Andrade; Jorge Lima; coelho, man; Joana A Loureiro; Maria do Carmo Pereira
Conjugation with anti-transferrinreceptor antibody increases PLGAnanoparticles uptake in Glioblastomacells (2018)
Summary of Presentation in an International Conference
Maria Ramalho; Jorge Lima; coelho, man; Joana A Loureiro; Maria do Carmo Pereira
Anti-transferrin receptor antibody conjugated PLGA nanoparticles for temozolomide (2017)
Summary of Presentation in an International Conference
Maria J. Ramalho; Joana A Loureiro; Jorge Lima; coelho, man; Maria do Carmo Pereira
Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment (2018)
Article in International Scientific Journal
Maria João Ramalho; E. Sevin; F. Gosselet ; J. Lima; Manuel A. Coelho; Joana A. Loureiro; Maria do Carmo Pereira

See all (10)

Of the same journal

Second-Generation Antimitotics in Cancer Clinical Trials (2021)
Another Publication in an International Scientific Journal
Novais, P; Silva, PMA; Maria Isabel Amorim; Bousbaa, H
Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies (2020)
Another Publication in an International Scientific Journal
Teixeira, MI; Maria Helena Amaral; Paulo Costa; Lopes, CM; Lamprou, DA
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence (2020)
Another Publication in an International Scientific Journal
Menditto, E; Orlando, V; De Rosa, G; Minghetti, P; Musazzi, UM; Cahir, C; Kurczewska Michalak, M; Kardas, P; Costa, E; Sousa Lobo JM; Almeida, IF
Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU (2020)
Another Publication in an International Scientific Journal
Souto, EB; Silva, GF; Dias Ferreira, J; Zielinska, A; Ventura, F; Durazzo, A; Lucarini, M; Novellino, E; Santini, A
Magnetic Bone Tissue Engineering: Reviewing the Effects of Magnetic Stimulation on Bone Regeneration and Angiogenesis (2023)
Another Publication in an International Scientific Journal
Ribeiro, TP; Flores, M; Madureira, S; Zanotto, F; Fernando Mendes Monteiro; Laranjeira, MS

See all (92)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Arquitectura da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-08-31 at 21:20:26 | Acceptable Use Policy | Data Protection Policy | Complaint Portal